RENSSELAER, N.Y., June 11 (Bernama-GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
Immunodeficient animal models are critical to the drug discovery ecosystem. One of the most common contributors to the high product attrition rate for this industry is difficulty recapitulating the human biosystem in an animal model. Immunodeficient models bridge this gap by enabling foreign tissue to interact with the animal, without rejection by that animals’ immune system. Better replication of the human body in mice is a driving force in many revolutionary medical advances, including immuno-oncology and personalized medicine.